GlaxoSmithKline Biologicals
Rixensart
19 articles about GlaxoSmithKline Biologicals
-
GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine
7/20/2023
LimmaTech Biologics AG signed an in-license agreement with GlaxoSmithKline Biologicals SA enabling LimmaTech Bio to further develop and commercialize a quadrivalent bioconjugate vaccine candidate for shigellosis that GSK added to its infectious disease pipeline when LimmaTech Bio’s predecessor company, GlycoVaxyn, was acquired by GSK in 2015.
-
Life Technologies Signs Agreement with GlaxoSmithKline Biologicals, Seeking Expanded Use of Platform Technologies into Companion Diagnostics
10/26/2011
-
Nabi Biopharmaceuticals Completes Third PentaStaph(TM) Milestone; $8 Million Payment Due from GlaxoSmithKline Biologicals
8/10/2010
-
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
2/9/2010
-
Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone; Company to Receive $8 Million Payment from GlaxoSmithKline Biologicals
2/8/2010
-
Nabi Biopharmaceuticals to Receive $5 Million Milestone Payment From GlaxoSmithKline Biologicals
12/9/2009
-
World's Largest Malaria Vaccine Trial Now Underway In 7 African Countries, GlaxoSmithKline Biologicals Study
11/3/2009
-
FDA Approves GlaxoSmithKline Biologicals Seasonal Influenza Vaccine Fluarix for Pediatric Use
10/20/2009
-
FDA Approves 2008-2009 Season's Flu Vaccines: CSL Limited, Afluria. GlaxoSmithKline Biologicals, Fluarix. ID Biomedical Corporation of Quebec, FluLaval. MedImmune Vaccines, FluMist. Novartis Vaccines & Diagnostics, Inc., Fluvirin. Sanofi Pasteur, Fluzone.
8/6/2008
-
ADHD Drugs To Have Stronger Warning; Include Novartis International AG's Dexedrine And GlaxoSmithKline Biologicals's Ritalin
8/22/2006
-
Antigenics Inc. (New York) Announces Expansion Of Its License And Supply Agreement With GlaxoSmithKline Biologicals For QS-21 Stimulon(R) Adjuvant
7/10/2006
-
GlaxoSmithKline Biologicals Release: Malaria Vaccine Can Save Millions
4/25/2006
-
Avant Immunotherapeutics Announces European Regulatory Authorities Approve Rotarix(R) Rotavirus Vaccine
2/27/2006
-
Measles Vaccine "Could Fight AIDS"
11/28/2005
-
GlaxoSmithKline Biologicals Release: New Results Show The RTS,S Malaria Vaccine Candidate Protects Children for At Least 18 Months
11/15/2005
-
New Bill & Melinda Gates Foundation Funding Will Enable Malaria Vaccine Initiative, PATH And GlaxoSmithKline Biologicals To Complete Development Of World's Most Advanced Malaria Vaccine Candidate
10/31/2005
-
GlaxoSmithKline Consumer Healthcare Launches Suit To Stop Misleading Marketing Of Unproven Herbal Smoking Cessation Therapy
2/9/2005
-
European Flu Vaccine To Be Tested In U.S.
12/13/2004
-
Diarrheal Disease Vaccine Shows Promise
11/1/2004